# Alora Pharmaceuticals – FDA Inspection, Mar 29, 2019

Source: https://www.keypedia.com/records/fda_inspections/alora-pharmaceuticals/c4aa737c-7804-4d1a-805b-ec94a1b10c38
Source feed: FDA_Inspections

> FDA inspection 1085822 of Alora Pharmaceuticals, March 29, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 314. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1085822
- Company Name: Alora Pharmaceuticals
- Inspection Date: 2019-03-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1312272 - 2026-04-13](https://www.keypedia.com/records/fda_inspections/alora-pharmaceuticals/38a374e9-b736-4d83-9e61-6551e192e337)
- FDA Inspection 1048852 - 2017-12-21
- FDA Inspection 1028389 - 2017-09-11
- [FDA Inspection 1014708 - 2017-03-08](https://www.keypedia.com/records/fda_inspections/alora-pharmaceuticals/ac65f52f-03de-4b96-9345-4bca54cd5890)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/vanessa-e-coulter/add8407c-0df8-43ed-9f5a-8063880ce638)

Company: https://www.keypedia.com/companies/alora-pharmaceuticals/cb52e370-b082-4899-a6b3-e88d5a3d3797

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c